IRVINE, Calif., July 30, 2008 (PRIME NEWSWIRE) -- BIOLASE Technology, Inc. (Nasdaq:BLTI), the world's leading dental laser company, announced today that the Company will host a conference call on Thursday, August 7 at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter and six months ended June 30, 2008 and to answer questions. The Company's results release will be distributed at approximately 4:05 p.m. Eastern Time that same day.
Slides will be used during this call. Directions for accessing the slides can be found below.
Phone Participation
To listen to the conference call live via telephone, please dial 1-800-762-9058 from the U.S. or, for international callers, please dial +1-480-629-9572, approximately 10 minutes before the start time. In order to access the slides that will be used on the call, click on the link provided on the Investors section of the BIOLASE website at www.biolase.com to listen to the event, register and select the "No Audio, Slides Only" option.
Webcast Participation
To listen to the conference call live via the Internet, visit the Investors section of the BIOLASE website at www.biolase.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software.
Replay
A telephone replay will be available for two days by dialing 1-800-406-7325 from the U.S., or +1-303-590-3030 for international callers, and entering passcode number 3904490. In addition, a replay will be available on BIOLASE's website.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, develops, manufactures and markets lasers and related products that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.